BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,045 filers reported holding BAXTER INTL INC in Q4 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,077 | -85.0% | 532 | -81.9% | 0.00% | -80.0% |
| Q2 2023 | $133,901 | -4.0% | 2,939 | -14.5% | 0.01% | 0.0% |
| Q1 2023 | $139,486 | +6.4% | 3,439 | +33.7% | 0.01% | 0.0% |
| Q4 2022 | $131,146 | -12.6% | 2,573 | -7.8% | 0.01% | -16.7% |
| Q3 2022 | $150,000 | -43.4% | 2,790 | -32.5% | 0.01% | -33.3% |
| Q2 2022 | $265,000 | -19.7% | 4,135 | -3.0% | 0.01% | -50.0% |
| Q1 2022 | $330,000 | -9.8% | 4,263 | +0.1% | 0.02% | +63.6% |
| Q4 2021 | $366,000 | +5.5% | 4,260 | -1.5% | 0.01% | 0.0% |
| Q3 2021 | $347,000 | -3.6% | 4,323 | -3.3% | 0.01% | -42.1% |
| Q2 2021 | $360,000 | -46.9% | 4,469 | -44.4% | 0.02% | -51.3% |
| Q1 2021 | $678,000 | +5.0% | 8,044 | 0.0% | 0.04% | -9.3% |
| Q4 2020 | $646,000 | -0.2% | 8,044 | 0.0% | 0.04% | -10.4% |
| Q3 2020 | $647,000 | -3.9% | 8,044 | +2.9% | 0.05% | -9.4% |
| Q2 2020 | $673,000 | +8.9% | 7,819 | +2.8% | 0.05% | -8.6% |
| Q1 2020 | $618,000 | -5.4% | 7,609 | -2.5% | 0.06% | +20.8% |
| Q4 2019 | $653,000 | -5.9% | 7,804 | -1.6% | 0.05% | -11.1% |
| Q3 2019 | $694,000 | +6.9% | 7,929 | 0.0% | 0.05% | +8.0% |
| Q2 2019 | $649,000 | +8.9% | 7,929 | +8.2% | 0.05% | +4.2% |
| Q1 2019 | $596,000 | +24.4% | 7,329 | +0.7% | 0.05% | +11.6% |
| Q4 2018 | $479,000 | -19.9% | 7,275 | -6.2% | 0.04% | -8.5% |
| Q3 2018 | $598,000 | +4.0% | 7,758 | -0.4% | 0.05% | -2.1% |
| Q2 2018 | $575,000 | -5.3% | 7,786 | -16.7% | 0.05% | -18.6% |
| Q1 2018 | $607,000 | -1.5% | 9,343 | -1.9% | 0.06% | 0.0% |
| Q4 2017 | $616,000 | +2.5% | 9,524 | -0.6% | 0.06% | -4.8% |
| Q3 2017 | $601,000 | +3.6% | 9,580 | -0.1% | 0.06% | -1.6% |
| Q2 2017 | $580,000 | +16.5% | 9,590 | 0.0% | 0.06% | +10.5% |
| Q1 2017 | $498,000 | +9.0% | 9,590 | -0.4% | 0.06% | -1.7% |
| Q4 2016 | $457,000 | 0.0% | 9,626 | 0.0% | 0.06% | 0.0% |
| Q3 2016 | $457,000 | -14.7% | 9,626 | -18.9% | 0.06% | -20.5% |
| Q2 2016 | $536,000 | +10.3% | 11,869 | +0.3% | 0.07% | +35.2% |
| Q1 2016 | $486,000 | +9.2% | 11,831 | +1.3% | 0.05% | -31.6% |
| Q4 2015 | $445,000 | +34.0% | 11,676 | +15.5% | 0.08% | +54.9% |
| Q3 2015 | $332,000 | -54.4% | 10,110 | -2.9% | 0.05% | -51.9% |
| Q2 2015 | $728,000 | +2.0% | 10,417 | -0.1% | 0.11% | +2.9% |
| Q1 2015 | $714,000 | -5.8% | 10,429 | +0.9% | 0.10% | -11.2% |
| Q4 2014 | $758,000 | +5.1% | 10,341 | +2.8% | 0.12% | +2.7% |
| Q3 2014 | $721,000 | -2.3% | 10,063 | -1.4% | 0.11% | +5.6% |
| Q2 2014 | $738,000 | -8.2% | 10,202 | -6.7% | 0.11% | -5.3% |
| Q1 2014 | $804,000 | +7.1% | 10,930 | +1.0% | 0.11% | +0.9% |
| Q4 2013 | $751,000 | +4317.6% | 10,817 | +4175.5% | 0.11% | +3633.3% |
| Q3 2013 | $17,000 | +30.8% | 253 | +38.3% | 0.00% | -57.1% |
| Q2 2013 | $13,000 | 0.0% | 183 | 0.0% | 0.01% | 0.0% |
| Q1 2013 | $13,000 | +8.3% | 183 | 0.0% | 0.01% | -22.2% |
| Q4 2012 | $12,000 | +200.0% | 183 | +185.9% | 0.01% | +200.0% |
| Q3 2012 | $4,000 | -75.0% | 64 | -74.8% | 0.00% | -76.9% |
| Q2 2012 | $16,000 | +14.3% | 254 | +19.2% | 0.01% | +8.3% |
| Q1 2012 | $14,000 | – | 213 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |